Hypoxia-Inducible Factor-2αLimits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hypoxia-Inducible Factor-2αLimits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury

Published:2015-05-08 Issue:1 Volume:27 Page:92-106
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Zhang Jianjun,Han Conghui,Dai Huijuan,Hou Jianquan,Dong Yang,Cui Xiaolan,Xu Longmei,Zhang Ming,Xia Qiang

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference54 articles.

1. The interaction between ischemia–reperfusion and immune responses in the kidney

2. Triggers of inflammation after renal ischemia/reperfusion

3. Ischemia–reperfusion and immediate T cell responses

4. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice.;Rabb;Am J Physiol Renal Physiol,2000

5. Identification of the CD4+ T cell as a major pathogenic factor in ischemic acute renal failure

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIF-2α-dependent induction of miR-29a restrains TH1 activity during T cell dependent colitis;Nature Communications;2024-09-14

2. A Novel 6-Bp-Repeat-Unit (6-Bp-Ru) of the 13th Intron within the Conserved Epas1 Gene in Plateau Pika is Capable of Altering Enhancer Activity;2024

3. Mechanisms of HIF-driven immunosuppression in tumour microenvironment;Journal of the Egyptian National Cancer Institute;2023-08-30

4. Sufentanil inhibits Pin1 to attenuate renal tubular epithelial cell ischemia–reperfusion injury by activating the PI3K/AKT/FOXO1 pathway;International Urology and Nephrology;2023-06-10

5. Long-term treatment of chronic kidney disease patients with anemia using hypoxia-inducible factor prolyl hydroxylase inhibitors: potential concerns;Pediatric Nephrology;2023-06-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3